Characteristics, Comorbidities, and Data Gaps for Coronavirus Disease Deaths, Tennessee, USA

Emerg Infect Dis. 2021 Oct;27(10):2521-2528. doi: 10.3201/eid2710.211070.ABSTRACTAs of March 2021, coronavirus disease (COVID-19) had led to>500,000 deaths in the United States, and the state of Tennessee had the fifth highest number of cases per capita. We reviewed the Tennessee Department of Health COVID-19 surveillance and chart-abstraction data during March 15‒August 15, 2020. Patients who died from COVID-19 were more likely to be older, male, and Black and to have underlying conditions (hereafter comorbidities) than case-patients who survived. We found 30.4% of surviving case-patients and 20.3% of deceased patients had no comorbidity information recorded. Chart-abstraction captured a higher proportion of deceased case-patients with>1 comorbidity (96.3%) compared with standard surveillance deaths (79.0%). Chart-abstraction detected higher rates of each comorbidity except for diabetes, which had similar rates among standard surveillance and chart-abstraction. Investing in public health data collection infrastructure will be beneficial for the COVID-19 pandemic and future disease outbreaks.PMID:34545796 | DOI:10.3201/eid2710.211070
Source: Emerging Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research

Related Links:

In this report, the first case of COVID-19 positive C.auris fungemia detected in Turkey was presented. A 71-year-old male patient with a history of myocardial infarction, diabetes mellitus, donation of a single kidney and lobectomy surgery due to lung cancer was hospitalized in the pandemic thoracic surgery service due to the findings consistent with viral pneumonia on thoracic computed tomography. Favipiravir 2 x 600 mg and intravenous dexamethasone 1 x 6 mg therapy was administered. The patient tested positive for SARS-CoV-2 polymerase chain reaction, and severe involvement of the left lung was detected in the following ...
Source: Mikrobiyoloji Bulteni - Category: Microbiology Authors: Source Type: research
World J Orthop. 2021 Sep 18;12(9):620-628. doi: 10.5312/wjo.v12.i9.620. eCollection 2021 Sep 18.ABSTRACTAn acute respiratory illness caused by a novel coronavirus, namely, severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019 (COVID-19), began spreading across China in late December 2019. The disease gained global attention as it spread worldwide. Since the COVID-19 pandemic began, many studies have focused on the impact of the disease on conditions such as diabetes, cardiovascular disease, pulmonary disorders, and renal malfunction. However, few studies have focused on musculoskel...
Source: World Journal of Orthopaedics - Category: Orthopaedics Authors: Source Type: research
Emerg Infect Dis. 2021 Sep 29;28(1). doi: 10.3201/eid2801.211636. Online ahead of print.ABSTRACTWe provide an overview of the epidemiology and clinical course of mucormycosis in the coronavirus disease (COVID-19) pandemic era. We conducted a retrospective chart review of 178 patients with clinical or diagnostic, endoscopically or histopathologically confirmed rhino-sino-orbital or cerebral mucormycosis after COVID-19 treatment during the second wave of COVID-19 in Pune, India. Median time to symptom onset from COVID-19 detection was 28 days. Moderate or severe COVID-19 was seen in 73% of patients and diabetes in 74.2%. A t...
Source: Emerging Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
Emerg Infect Dis. 2021 Oct;27(10):2521-2528. doi: 10.3201/eid2710.211070.ABSTRACTAs of March 2021, coronavirus disease (COVID-19) had led to>500,000 deaths in the United States, and the state of Tennessee had the fifth highest number of cases per capita. We reviewed the Tennessee Department of Health COVID-19 surveillance and chart-abstraction data during March 15‒August 15, 2020. Patients who died from COVID-19 were more likely to be older, male, and Black and to have underlying conditions (hereafter comorbidities) than case-patients who survived. We found 30.4% of surviving case-patients and 20.3% of deceased patien...
Source: Emerging Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
More News: Coronavirus | COVID-19 | Department of Health | Diabetes | Endocrinology | Infectious Diseases | International Medicine & Public Health | Outbreaks | Pandemics | USA Health